ABSTRACT
Background In March 2020 South Africa implemented strict non-pharmaceutical interventions (NPIs) to contain Covid-19. Over the subsequent five months NPIs were eased in stages according to national strategy. Covid-19 spread throughout the country heterogeneously, reaching rural areas by July and peaking in July-August. Data on the impact of NPI policies on social and economic wellbeing and access to healthcare is limited. We therefore analysed how rural residents of three South African provinces changed their behaviour during the first epidemic wave.
Methods The South African Population Research Infrastructure Network (SAPRIN) nodes in Mpumalanga (Agincourt), KwaZulu-Natal (AHRI) and Limpopo (DIMAMO) provinces conducted longitudinal telephone surveys among randomly sampled households from rural and peri-urban surveillance populations every 2-3 weeks. Interviews included questions on: Covid-19 knowledge and behaviours; health and economic impact of NPIs; and mental health.
Results 2262 households completed 10,966 interviews between April and August 2020. By August, self-reported satisfaction with Covid-19 knowledge had risen from 48% to 85% and facemask use to over 95%. As selected NPIs were eased mobility increased, and economic losses and anxiety and depression symptoms fell. When Covid-19 cases spiked at one node in July, movement dropped rapidly, and missed daily medication rates doubled. Economic concerns and mental health symptoms were lower in households receiving a greater number of government-funded old-age pensions.
Conclusions South Africans reported complying with stringent Covid-19 NPIs despite the threat of substantial social, economic and health repercussions. Government-supported social welfare programmes appeared to buffer interruptions in income and healthcare access during local outbreaks. Epidemic control policies must be balanced against impacts on wellbeing in resource-limited settings and designed with parallel support systems where they threaten income and basic service access.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Core surveillance activities including the Covid-19 telephonic surveillance at all three nodes are wholly or in part funded by the South African Department of Science and Innovation through the South African Population Research Infrastructure Network hosted by the South African Medical Research Council. The MRC/Wits Rural Public Health and Health Transitions Research Unit which hosts the Agincourt Health and Socio-Demographic Surveillance System is also supported by the University of the Witwatersrand and Medical Research Council, South Africa. DIMAMO Population Health Research Centre receives funding from the National Institutes of Health and is supported by the Human Heredity and Health in Africa (H3Africa) Consortium. African Health Research Institute receives funding from the Wellcome Trust (Grant 201433/Z/16/Z) for aspects of its health and demographic surveillance. GH is supported by a fellowship from the Royal Society and the Wellcome Trust (210479/Z/18/Z). EBW is supported by the National Institutes of Health (NIAID K08AI118538 and FIC R21TW011687). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All study procedures were discussed with each nodes' existing community advisory groups and approved by Limpopo, Mpumalanga and KwaZulu-Natal's provincial Department of Health Research Ethics Committees (REC), the University of KwaZulu-Natal's Biomedical REC, the University of the Witwatersrand's Human REC (Medical) and the University of Limpopo's Turfloop REC.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data collected in the SAPRIN Covid-19 high-intensity surveillance study will be made available in pseudonymized form through Figshare and the SAPRIN data repository (http://saprindata.samrc.ac.za/index.php/catalog). Data reported in this article will be available on peer-reviewed publication. Data from ongoing SAPRIN surveillance is shared on the SAPRIN data repository.
List of abbreviations
- AHRI
- Africa Health Research Institute
- GAD-2
- Generalized Anxiety Disorder 2-item
- HDSS
- Health and Demographic Surveillance System
- NPI
- Non-Pharmaceutical Intervention
- PHQ-2
- Patient Health Questionnaire 2-item
- REC
- Research Ethics Committee
- SAPRIN
- South African Population Research Infrastructure Network
